Literature DB >> 25829137

Subclinical Carotid Atherosclerosis in Asymptomatic Subjects With Type 2 Diabetes Mellitus.

Esther Rubinat1, Josep Ramon Marsal, Teresa Vidal, Cristina Cebrian, Mireia Falguera, Ma Belen Vilanova, Àngels Betriu, Elvira Fernández, Josep Franch, Dídac Mauricio.   

Abstract

BACKGROUND: Subjects with type 2 diabetes mellitus are considered to be at high risk for cardiovascular disease. The identification of carotid atherosclerosis is a validated surrogate marker of cardiovascular disease. Nurses are key professionals in the improvement and intensification of cardiovascular preventive strategies. AIMS: The aim is to study the presence of carotid atherosclerosis in a group of asymptomatic subjects with type 2 diabetes mellitus and no previous clinical cardiovascular disease.
METHODS: A total of 187 patients with type 2 diabetes mellitus and 187 age- and sex-matched subjects without type 2 diabetes mellitus were studied in this cross-sectional, observational, cohort study. Standard operational procedures were applied by the nursing team regarding physical examination and carotid ultrasound assessment. Common, bulb, and internal carotid arteries were explored by measuring intima-media thickness and identifying atherosclerotic plaques.
RESULTS: Carotid intima-media thickness (c-IMT) and carotid plaque prevalence were significantly greater in diabetic subjects than in the control group. Carotid plaques and c-IMT were more frequent in men than in women and increased with increasing age. In the multivariate analysis, age, gender, waist circumference, systolic blood pressure, and hypercholesterolemia were positively associated with c-IMT, whereas age, gender, and weight were positively associated with carotid plaque.
CONCLUSION: The current nurse-led study shows that subjects with type 2 diabetes mellitus have a high prevalence of subclinical atherosclerosis that is associated with cardiovascular risk factors.

Entities:  

Mesh:

Year:  2016        PMID: 25829137     DOI: 10.1097/JCN.0000000000000236

Source DB:  PubMed          Journal:  J Cardiovasc Nurs        ISSN: 0889-4655            Impact factor:   2.083


  6 in total

1.  Association of Risk Estimates of Three Different Cardiovascular Risk Assessment Tools with Carotid Intima Media Thickness in Patients with Type 2 Diabetes.

Authors:  Herath Mudiyanselage Meththananda Herath; Thilak Priyantha Weerarathna; Ranasinghe Bethmi Arachige Thilini Dulanjalee; Madumekala Rupasinghe Jayawardana; Udara Priyadarshani Edirisingha; Madushanka Rathnayake
Journal:  J Clin Diagn Res       Date:  2016-07-01

2.  Hypertension, C Reactive Protein and Metabolic Profile: What is the Scenario in Patients Undergoing Arteriography?

Authors:  Ricardo Jose Tofano; Sandra Maria Barbalho; Marcelo Dib Bechara; Karina Quesada; Claudemir Gregorio Mendes; Marie Oshiiwa
Journal:  J Clin Diagn Res       Date:  2017-08-01

3.  Modifiable risk factors for carotid atherosclerosis: a meta-analysis and systematic review.

Authors:  Xi Ji; Xin-Yi Leng; Yi Dong; Ya-Hui Ma; Wei Xu; Xi-Peng Cao; Xiao-He Hou; Qiang Dong; Lan Tan; Jin-Tai Yu
Journal:  Ann Transl Med       Date:  2019-11

4.  Prevalence, clinical features and risk assessment of pre-diabetes in Spain: the prospective Mollerussa cohort study.

Authors:  María Belén Vilanova; Mireia Falguera; Josep Ramon Marsal; Esther Rubinat; Núria Alcubierre; Esmeralda Castelblanco; Minerva Granado-Casas; Neus Miró; Àngels Molló; Manel Mata-Cases; Josep Franch-Nadal; Didac Mauricio
Journal:  BMJ Open       Date:  2017-06-11       Impact factor: 2.692

5.  Texture Analysis Based on Vascular Ultrasound to Identify the Vulnerable Carotid Plaques.

Authors:  Lianlian Zhang; Qi Lyu; Yafang Ding; Chunhong Hu; Pinjing Hui
Journal:  Front Neurosci       Date:  2022-06-02       Impact factor: 5.152

6.  Tanshinone IIA inhibits AGEs-induced proliferation and migration of cultured vascular smooth muscle cells by suppressing ERK1/2 MAPK signaling.

Authors:  Ming Lu; Ying Luo; Pengfei Hu; Liping Dou; Shuwei Huang
Journal:  Iran J Basic Med Sci       Date:  2018-01       Impact factor: 2.699

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.